Literature DB >> 22695070

Biscarbamate cross-linked low molecular weight PEI for delivering IL-1 receptor antagonist gene to synoviocytes for arthritis therapy.

Shengnan Xiang1, Jing Su, Haijun Tong, Fei Yang, Wenxue Tong, Weien Yuan, Fei Wu, Chuandong Wang, Tuo Jin, Kerong Dai, Xiaoling Zhang.   

Abstract

Cytoxicity is an essential concern for polyethyleneimine 25 kDa (PEI 25 kDa), a widely reported, highly effective transfection agent used in gene delivery. In our recent experiments, Small molecular weight cross-linked poly(ethylene imine) by biscarbamate linkage (PEI-Bu) (Mn: 3278, Mw: 4289) can reduce target cell apoptosis induced by polycationic transfection, and has almost the same DNA condensation capability as PEI 25 kDa. PEI-Bu showed significantly higher activity and lower cytotoxicity than PEI 25 kDa in transfecting the anti-inflammatory cytokine interleukin-1 receptor antagonist (IL-1Ra) gene to rat synoviocytes, an optimal target for arthritis treatment. The expression of IL-1Ra in synoviocytes then suppresses the expression of metalloproteases 13 (MMP13) gene, which is responsible for cartilage destruction regulated by IL-1β in arthritis. In conclusion, PEI-Bu is a promising tool for delivering IL-1Ra gene to synoviocytes for arthritis therapy.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22695070     DOI: 10.1016/j.biomaterials.2012.05.044

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  14 in total

1.  Trigger-responsive, fast-degradable poly(β-amino ester)s for enhanced DNA unpackaging and reduced toxicity.

Authors:  Xiaojian Deng; Nan Zheng; Ziyuan Song; Lichen Yin; Jianjun Cheng
Journal:  Biomaterials       Date:  2014-03-24       Impact factor: 12.479

2.  Maximizing gene delivery efficiencies of cationic helical polypeptides via balanced membrane penetration and cellular targeting.

Authors:  Nan Zheng; Lichen Yin; Ziyuan Song; Liang Ma; Haoyu Tang; Nathan P Gabrielson; Hua Lu; Jianjun Cheng
Journal:  Biomaterials       Date:  2013-11-07       Impact factor: 12.479

3.  Delivery of therapeutic AGT shRNA by PEG-Bu for hypertension therapy.

Authors:  Yu-Qiang Wang; Fei Wang; Xiao-Qin Deng; Jing Sheng; Shu-Yan Chen; Jing Su
Journal:  PLoS One       Date:  2013-07-19       Impact factor: 3.240

4.  Effects of phosphorylatable short peptide-conjugated chitosan-mediated IL-1Ra and igf-1 gene transfer on articular cartilage defects in rabbits.

Authors:  Ronglan Zhao; Xiaoxiang Peng; Qian Li; Wei Song
Journal:  PLoS One       Date:  2014-11-12       Impact factor: 3.240

5.  Efficient and Non-Toxic Biological Response Carrier Delivering TNF-α shRNA for Gene Silencing in a Murine Model of Rheumatoid Arthritis.

Authors:  Jialin Song; Yinghui Chen; Shichao Jiang; Kejia Yang; Xiaoming Li; Xiaotian Zhao; Yuanming Ouyang; Cunyi Fan; Weien Yuan
Journal:  Front Immunol       Date:  2016-08-19       Impact factor: 7.561

Review 6.  Immune Activities of Polycationic Vectors for Gene Delivery.

Authors:  Xiaotian Zhao; Xiaoming Li; Yi Zhao; Yuan Cheng; Yunqi Yang; Zhiwei Fang; Yangmei Xie; Yao Liu; Yinghui Chen; Yuanming Ouyang; Weien Yuan
Journal:  Front Pharmacol       Date:  2017-08-04       Impact factor: 5.810

7.  Biodegradable Carriers for Delivery of VEGF Plasmid DNA for the Treatment of Critical Limb Ischemia.

Authors:  Guang Liu; Zhiwei Fang; Minglu Yuan; Weimin Li; Yunqi Yang; Mier Jiang; Yuanming Ouyang; Weien Yuan
Journal:  Front Pharmacol       Date:  2017-08-09       Impact factor: 5.810

8.  Biscarbamate cross-linked low molecular weight Polyethylenimine polycation as an efficient intra-cellular delivery cargo for cancer therapy.

Authors:  Xuemei Ge; Jia Feng; Shun Chen; Can Zhang; Yuanming Ouyang; Zhenguo Liu; Weien Yuan
Journal:  J Nanobiotechnology       Date:  2014-04-06       Impact factor: 10.435

9.  In vivo therapeutic efficacy of TNFα silencing by folate-PEG-chitosan-DEAE/siRNA nanoparticles in arthritic mice.

Authors:  Qin Shi; Elsa-Patricia Rondon-Cavanzo; Isadora Pfeifer Dalla Picola; Marcio José Tiera; Xiaoling Zhang; Kerong Dai; Houda Abir Benabdoune; Mohamed Benderdour; Julio Cesar Fernandes
Journal:  Int J Nanomedicine       Date:  2018-01-12

Review 10.  Profile of sarilumab and its potential in the treatment of rheumatoid arthritis.

Authors:  Maria Gabriella Raimondo; Martina Biggioggero; Chiara Crotti; Andrea Becciolini; Ennio Giulio Favalli
Journal:  Drug Des Devel Ther       Date:  2017-05-24       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.